Renerva Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $335K

  • Investors
  • 10

Renerva General Information

Description

Developer of medical device implants intended to offer surgical devices to facilitate nerve repair, recovery, and storage. The company's implants focus on peripheral treatment to improve function, and outcome and accelerate healing, enabling doctors to help patients to accelerate healing and return function following nerve injury.

Contact Information

Website
www.renerva.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2403 Sidney Street
  • Suite 280
  • Pittsburgh, PA 15203
  • United States
+1 (412)
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Corporate Office
  • 2403 Sidney Street
  • Suite 280
  • Pittsburgh, PA 15203
  • United States
+1 (412)

Renerva Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Renerva Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC 15-Aug-2024 $335K Completed Product In Beta Test
13. Grant 01-Jan-2023 Completed Product In Beta Test
12. Grant 24-Feb-2022 Completed Product In Beta Test
11. Early Stage VC 01-Jun-2021 Completed Product In Beta Test
10. Accelerator/Incubator 09-Jan-2020 Completed Product In Beta Test
9. Grant 01-Sep-2019 Completed Product In Beta Test
8. Grant 01-Jul-2019 Completed Product In Beta Test
7. Seed Round 30-Apr-2019 Completed Product In Beta Test
6. Grant 14-Dec-2018 $2.44M $1.01M Completed Startup
5. Seed Round 03-Aug-2018 $640K $1.01M Completed Startup
To view Renerva’s complete valuation and funding history, request access »

Renerva Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 15

    Pending

  • Expiring in next 12 mo

Renerva Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022425103-A1 Neurorrhaphy systems, devices, and methods Pending 31-Dec-2021
AU-2022425103-A2 Neurorrhaphy systems, devices, and methods Pending 31-Dec-2021
AU-2022353834-A1 Nerve graft systems, devices, and methods Pending 30-Sep-2021
CA-3232270-A1 Nerve graft systems, devices, and methods Pending 30-Sep-2021
EP-4408446-A2 Nerve graft systems, devices, and methods Pending 30-Sep-2021 A61K35/30
To view Renerva’s complete patent history, request access »

Renerva Executive Team (3)

Name Title Board Seat
Lorenzo Soletti Ph.D Co-Founder, President, Chief Executive Officer & Board Member
Bryan Brown Ph.D Co-Founder & Chief Technology Officer
Paul Gardner MD Chief Medical Officer
To view Renerva’s complete executive team members history, request access »

Renerva Board Members (2)

Name Representing Role Since
Peter DeComo Self Board Member
William Sekkel Self Board Member
To view Renerva’s complete board members history, request access »

Renerva Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Renerva Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Keiretsu Forum Venture Capital Minority
Rochester Angel Network Angel Group Minority
Kevin M. McGovern Family Center for Venture Development in the Life Sciences Accelerator/Incubator Minority
National Institute on Deafness and Other Communication Disorders Government
National Science Foundation Government
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Renerva FAQs

  • When was Renerva founded?

    Renerva was founded in 2017.

  • Who is the founder of Renerva?

    Lorenzo Soletti Ph.D and Bryan Brown Ph.D are the founders of Renerva.

  • Who is the CEO of Renerva?

    Lorenzo Soletti Ph.D is the CEO of Renerva.

  • Where is Renerva headquartered?

    Renerva is headquartered in Pittsburgh, PA.

  • What is the size of Renerva?

    Renerva has 8 total employees.

  • What industry is Renerva in?

    Renerva’s primary industry is Surgical Devices.

  • Is Renerva a private or public company?

    Renerva is a Private company.

  • What is Renerva’s current revenue?

    The current revenue for Renerva is .

  • How much funding has Renerva raised over time?

    Renerva has raised $2.27M.

  • Who are Renerva’s investors?

    Keiretsu Forum, Rochester Angel Network, Kevin M. McGovern Family Center for Venture Development in the Life Sciences, National Institute on Deafness and Other Communication Disorders, and National Science Foundation are 5 of 10 investors who have invested in Renerva.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »